The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway
Open accessAbstract
High-dose intravenous immunoglobulin is a widely used therapeutic preparation of highly purified immunoglobulin G (IgG) antibodies. It is administered at high doses (1–2 grams per kilogram) for the suppression of autoantibody-triggered inflammation in a variety of clinical settings. This anti-inflammatory activity of intravenous immunoglobulin is triggered by a minor population of IgG crystallizable fragments (Fcs), with glycans terminating in α2,6 sialic acids (sFc) that target myeloid regulatory cells expressing the lectin dendritic-cell-specific ICAM-3 grabbing non-integrin (DC-SIGN; also known as CD209). Here, to characterize this response in detail, we generated humanized DC-SIGN mice (hDC-SIGN), and demonstrate that the anti-inflammatory activity of intravenous immunoglobulin can be recapitulated by the transfer of bone-marrow-derived sFc-treated hDC-SIGN+ macrophages or dendritic cells into naive recipients. Furthermore, sFc administration results in the production of IL-33, which, in turn, induces expansion of IL-4-producing basophils that promote increased expression of the inhibitory Fc receptor FcγRIIB on effector macrophages. Systemic administration of the TH2 cytokines IL-33 or IL-4 upregulates FcγRIIB on macrophages, and suppresses serum-induced arthritis. Consistent with these results, transfer of IL-33-treated basophils suppressed induced arthritic inflammation. This novel DC-SIGN–TH2 pathway initiated by an endogenous ligand, sFc, provides an intrinsic mechanism for maintaining immune homeostasis that could be manipulated to provide therapeutic benefit in autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., & Steinman, R. M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1693 · Cited by 3,738
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
Soumelis, V., Reche, P. A., Kanzler, H., Yuan, W., Edward, G., Homey, B., Gilliet, M., Ho, S., Antonenko, S., Lauerma, A., et al. (2002) · Nature Immunology · doi:10.1038/ni805 · Cited by 2,183
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Self-citationSignalling through C-type lectin receptors: shaping immune responses
Geijtenbeek, T. B. H., & Gringhuis, S. I. (2009) · Nature Reviews Immunology · doi:10.1038/nri2569 · Cited by 1,379
IL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo
Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00243-6 · Cited by 1,203
Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,053
Self-citationHow are TH2-type immune responses initiated and amplified?
Paul, W. E., & Zhu, J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2735 · Cited by 963
A mechanism for the initiation of allergen-induced T helper type 2 responses
Sokol, C. L., Barton, G. M., Farr, A. G., & Medzhitov, R. (2008) · Nature Immunology · doi:10.1038/ni1558 · Cited by 961
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc
Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C., & Ravetch, J. V. (2008) · Science · doi:10.1126/science.1154315 · Cited by 849
Self-citationAugmented humoral and anaphylactic responses in FcγRII-deficient mice
Takai, T., Ono, M., Hikida, M., Ohmori, H., & Ravetch, J. V. (1996) · Nature · doi:10.1038/379346a0 · Cited by 826
Self-citationFrom Systemic T Cell Self-Reactivity to Organ-Specific Autoimmune Disease via Immunoglobulins
Korganow, A.-S., Ji, H., Mangialaio, S., Duchatelle, V., Pelanda, R., Martin, T., Degott, C., Kikutani, H., Rajewsky, K., Pasquali, J.-L., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80045-x · Cited by 690
Wang, Y.-H., Angkasekwinai, P., Lu, N., Voo, K. S., Arima, K., Hanabuchi, S., Hippe, A., Corrigan, C. J., Dong, C., Homey, B., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070406 · Cited by 671
Gringhuis, S. I., den Dunnen, J., Litjens, M., van het Hof, B., van Kooyk, Y., & Geijtenbeek, T. B. H. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.012 · Cited by 586
IL25 elicits a multipotent progenitor cell population that promotes TH2 cytokine responses
Saenz, S. A., Siracusa, M. C., Perrigoue, J. G., Spencer, S. P., Urban Jr, J. F., Tocker, J. E., Budelsky, A. L., Kleinschek, M. A., Kastelein, R. A., Kambayashi, T., et al. (2010) · Nature · doi:10.1038/nature08901 · Cited by 555
Identification of a receptor required for the anti-inflammatory activity of IVIG
Anthony, R. M., Wermeling, F., Karlsson, M. C. I., & Ravetch, J. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810163105 · Cited by 547
Self-citationAnti-Inflammatory Actions of Intravenous Immunoglobulin
Nimmerjahn, F., & Ravetch, J. V. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090232 · Cited by 525
Self-citationAnalysis of Type 2 Immunity In Vivo with a Bicistronic IL-4 Reporter
Mohrs, M., Shinkai, K., Mohrs, K., & Locksley, R. M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00186-8 · Cited by 459
Soilleux, E. J., Morris, L. S., Leslie, G., Chehimi, J., Luo, Q., Levroney, E., Trowsdale, J., Montaner, L. J., Doms, R. W., Weissman, D., et al. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.3.445 · Cited by 458
Basophils Produce IL-4 and Accumulate in Tissues after Infection with a Th2-inducing Parasite
Min, B., Prout, M., Hu-Li, J., Zhu, J., Jankovic, D., Morgan, E. S., Urban, J. F., Dvorak, A. M., Finkelman, F. D., LeGros, G., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040590 · Cited by 443
Finkelman, F. D., Madden, K. B., Morris, S. C., Holmes, J. M., Boiani, N., Katona, I. M., & Maliszewski, C. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1235 · Cited by 366
Bruhns, P., Samuelsson, A., Pollard, J. W., & Ravetch, J. V. (2003) · Immunity · doi:10.1016/s1074-7613(03)00080-3 · Cited by 304
Self-citationBasophils are essential initiators of a novel type of chronic allergic inflammation
Obata, K., Mukai, K., Tsujimura, Y., Ishiwata, K., Kawano, Y., Minegishi, Y., Watanabe, N., & Karasuyama, H. (2007) · Blood · doi:10.1182/blood-2007-01-068718 · Cited by 294
van de Geijn, F. E., Wuhrer, M., Selman, M. H., Willemsen, S. P., de Man, Y. A., Deelder, A. M., Hazes, J. M., & Dolhain, R. J. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2892 · Cited by 274
Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1
Jeffrey, K. L., Brummer, T., Rolph, M. S., Liu, S. M., Callejas, N. A., Grumont, R. J., Gillieron, C., Mackay, F., Grey, S., Camps, M., et al. (2006) · Nature Immunology · doi:10.1038/ni1310 · Cited by 270
Seder, R. A., Paul, W. E., Dvorak, A. M., Sharkis, S. J., Kagey-Sobotka, A., Niv, Y., Finkelman, F. D., Barbieri, S. A., Galli, S. J., & Plaut, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2835 · Cited by 258
Pricop, L., Redecha, P., Teillaud, J.-L., Frey, J., Fridman, W. H., Sautès-Fridman, C., & Salmon, J. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.531 · Cited by 231
Scherer, H. U., van der Woude, D., Ioan‐Facsinay, A., el Bannoudi, H., Trouw, L. A., Wang, J., Häupl, T., Burmester, G., Deelder, A. M., Huizinga, T. W. J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27414 · Cited by 223
Granelli-Piperno, A., Pritsker, A., Pack, M., Shimeliovich, I., Arrighi, J.-F., Park, C. G., Trumpfheller, C., Piguet, V., Moran, T. M., & Steinman, R. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4265 · Cited by 208
Helper T cells regulate type-2 innate immunity in vivo
Shinkai, K., Mohrs, M., & Locksley, R. M. (2002) · Nature · doi:10.1038/nature01202 · Cited by 200
Hodges, A., Sharrocks, K., Edelmann, M., Baban, D., Moris, A., Schwartz, O., Drakesmith, H., Davies, K., Kessler, B., McMichael, A., et al. (2007) · Nature Immunology · doi:10.1038/ni1470 · Cited by 192
SIGN-R1 Contributes to Protection against Lethal Pneumococcal Infection in Mice
Lanoue, A., Clatworthy, M. R., Smith, P., Green, S., Townsend, M. J., Jolin, H. E., Smith, K. G. C., Fallon, P. G., & McKenzie, A. N. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040795 · Cited by 165
Ohmori, K., Luo, Y., Jia, Y., Nishida, J., Wang, Z., Bunting, K. D., Wang, D., & Huang, H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802870 · Cited by 134
IL-33 Exacerbates Autoantibody-Induced Arthritis
Xu, D., Jiang, H., Li, Y., Pushparaj, P. N., Kurowska‐Stolarska, M., Leung, B. P. L., Mu, R., Tay, H. K., McKenzie, A. N. J., McInnes, I. B., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902685 · Cited by 123
Schaefer, M., Reiling, N., Fessler, C., Stephani, J., Taniuchi, I., Hatam, F., Yildirim, A. Ö., Fehrenbach, H., Walter, K., Ruland, J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6836 · Cited by 91
Seder, R. A., Paul, W. E., Ben-Sasson, Z., Gros, G. S. L., Kagey‐Sobotka, A., Finkelman, F. D., Pierce, J. H., & Plaut, M. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000235345 · Cited by 88
Wang, M., Saxon, A., & Díaz-Sánchez, D. (1999) · Clinical Immunology · doi:10.1006/clim.1998.4628 · Cited by 68
Interleukin‐4 can be a key positive regulator of inflammatory arthritis
Ohmura, K., Nguyen, L. T., Locksley, R. M., Mathis, D. J., & Benoist, C. O. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21104 · Cited by 66
The In Vivo Cytokine Capture Assay for Measurement of Cytokine Production in the Mouse
Finkelman, F. D., Morris, S. C., Orekhova, T., & Sehy, D. W. (2003) · Current Protocols in Immunology · doi:10.1002/0471142735.im0628s54 · Cited by 44
New monoclonal anti-mouse DC-SIGN antibodies reactive with acetone-fixed cells
Cheong, C., de Matos, I. G., Choi, J., Schauer, J. D., Dandamudi, D. B., Shrestha, E., Makeyeva, J. A., Li, X., Li, P., Steinman, R. M., et al. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.06.006 · Cited by 16
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
IgG Subclasses and Allotypes: From Structure to Effector Functions
Vidarsson, G., Dekkers, G., & Rispens, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00520 · Cited by 2,667
Glycosylation in health and disease
Reily, C., Stewart, T. J., Renfrow, M. B., & Novak, J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0129-4 · Cited by 2,075
Structure and function of immunoglobulins
Schroeder, H. W., & Cavacini, L. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.046 · Cited by 1,905
Beyond binding: antibody effector functions in infectious diseases
Lu, L. L., Suscovich, T. J., Fortune, S. M., & Alter, G. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.106 · Cited by 825
Metadata
- Authors
- Anthony, R. M., Kobayashi, T., Wermeling, F., & Ravetch, J. V.
- Venue
- Nature
- Published
- 2011-06-19
- Volume
- 475
- Issue
- 7354
- Pages
- 110-113
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1985075809
- Cited by
- 633
- References
- 41
- FWCI
- 53.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.